These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 36197769)
1. Long Intergenic Non-Coding 00162 as Diagnostic Biomarker for Early-Stage Pancreatic Cancer. Chen M; Lu Y; Qin S; Hu Z; Chen H; Lu L; Mo C; Zhang X; Huang J; Qin X Ann Clin Lab Sci; 2022 Jul; 52(4):533-543. PubMed ID: 36197769 [TBL] [Abstract][Full Text] [Related]
2. Serum CA724 has no diagnostic value for gastrointestinal tumors. Cao H; Zhu L; Li L; Wang W; Niu X Clin Exp Med; 2023 Oct; 23(6):2433-2442. PubMed ID: 36920593 [TBL] [Abstract][Full Text] [Related]
3. Coagulation parameters for the differential diagnosis of pancreatic cancer in the early stage: a retrospective study. Jiaao L; Wanli G; Kai Z; Feng G; Yunpeng P Eur J Med Res; 2023 Oct; 28(1):436. PubMed ID: 37848965 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of combining preoperative inflammatory markers ratios with CA199 for patients with early-stage pancreatic cancer. Gu Y; Hua Q; Li Z; Zhang X; Lou C; Zhang Y; Wang W; Cai P; Zhao J BMC Cancer; 2023 Mar; 23(1):227. PubMed ID: 36899319 [TBL] [Abstract][Full Text] [Related]
5. The overexpression of long intergenic ncRNA00162 induced by RelA/p65 promotes growth of pancreatic ductal adenocarcinoma. Lu Y; Wu M; Fu J; Sun Y; Furukawa K; Ling J; Qin X; Chiao PJ Cell Prolif; 2020 May; 53(5):e12805. PubMed ID: 32364285 [TBL] [Abstract][Full Text] [Related]
6. Low serum miR-373 predicts poor prognosis in patients with pancreatic cancer. Hua Y; Chen H; Wang L; Wang F; Wang P; Ning Z; Li Y; Liu L; Chen Z; Meng Z Cancer Biomark; 2017 Jul; 20(1):95-100. PubMed ID: 28759959 [TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNAs LOC285194, RP11-462C24.1 and Nbla12061 in serum provide a new approach for distinguishing patients with colorectal cancer from healthy controls. Wang C; Yu J; Han Y; Li L; Li J; Li T; Qi P Oncotarget; 2016 Oct; 7(43):70769-70778. PubMed ID: 27683121 [TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA CCDC26 as a potential predictor biomarker contributes to tumorigenesis in pancreatic cancer. Peng W; Jiang A Biomed Pharmacother; 2016 Oct; 83():712-717. PubMed ID: 27470572 [TBL] [Abstract][Full Text] [Related]
9. Large intergenic non-coding RNA-ROR as a potential biomarker for the diagnosis and dynamic monitoring of breast cancer. Zhao T; Wu L; Li X; Dai H; Zhang Z Cancer Biomark; 2017 Aug; 20(2):165-173. PubMed ID: 28869448 [TBL] [Abstract][Full Text] [Related]
10. Value of multi-detector computed tomography combined with serum tumor markers in diagnosis, preoperative, and prognostic evaluation of pancreatic cancer. Su J; Wang Y; Shao H; You X; Li S World J Surg Oncol; 2022 Sep; 20(1):323. PubMed ID: 36175918 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer. Wu X; Lu XH; Xu T; Qian JM; Zhao P; Guo XZ; Yang XO; Jiang WJ Chin J Dig Dis; 2006; 7(3):170-4. PubMed ID: 16808798 [TBL] [Abstract][Full Text] [Related]
12. Trefoil factor(s) and CA19.9: A promising panel for early detection of pancreatic cancer. Jahan R; Ganguly K; Smith LM; Atri P; Carmicheal J; Sheinin Y; Rachagani S; Natarajan G; Brand RE; Macha MA; Grandgenett PM; Kaur S; Batra SK EBioMedicine; 2019 Apr; 42():375-385. PubMed ID: 30956167 [TBL] [Abstract][Full Text] [Related]
13. Circulating long non-coding RNA AFAP1-AS1 is a potential diagnostic biomarker for non-small cell lung cancer. Li W; Li N; Kang X; Shi K Clin Chim Acta; 2017 Dec; 475():152-156. PubMed ID: 29080690 [TBL] [Abstract][Full Text] [Related]
14. Circulating lncRNA ABHD11-AS1 serves as a biomarker for early pancreatic cancer diagnosis. Liu Y; Feng W; Liu W; Kong X; Li L; He J; Wang D; Zhang M; Zhou G; Xu W; Chen W; Gong A; Xu M J Cancer; 2019; 10(16):3746-3756. PubMed ID: 31333792 [No Abstract] [Full Text] [Related]
15. The efficacy evaluation of cryosurgery in pancreatic cancer patients with the expression of CD44v6, integrin-β1, CA199, and CEA. Zhou G; Chiu D; Qin D; Niu L; Cai J; He L; Huang W; Xu K Mol Biotechnol; 2012 Sep; 52(1):59-67. PubMed ID: 22382453 [TBL] [Abstract][Full Text] [Related]
16. Plasma-Derived Exosomal ALIX as a Novel Biomarker for Diagnosis and Classification of Pancreatic Cancer. Yang J; Zhang Y; Gao X; Yuan Y; Zhao J; Zhou S; Wang H; Wang L; Xu G; Li X; Wang P; Zou X; Zhu D; Lv Y; Zhang S Front Oncol; 2021; 11():628346. PubMed ID: 34026608 [TBL] [Abstract][Full Text] [Related]
17. Serum chemokine CXCL8 as a better biomarker for diagnosis and prediction of pancreatic cancer than its specific receptor CXCR2, C-reactive protein, and classic tumor markers CA 19-9 and CEA. Litman-Zawadzka A; Łukaszewicz-Zając M; Gryko M; Kulczyńska-Przybik A; Mroczko B Pol Arch Intern Med; 2018 Sep; 128(9):524-531. PubMed ID: 30057378 [TBL] [Abstract][Full Text] [Related]
18. Leukemia inhibitory factor is a novel biomarker to predict lymph node and distant metastasis in pancreatic cancer. Jiang W; Bai W; Li J; Liu J; Zhao K; Ren L Int J Cancer; 2021 Feb; 148(4):1006-1013. PubMed ID: 32914874 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic Value of Plasma miR-181b, miR-196a, and miR-210 Combination in Pancreatic Cancer. Liu G; Shao C; Li A; Zhang X; Guo X; Li J Gastroenterol Res Pract; 2020; 2020():6073150. PubMed ID: 32831826 [TBL] [Abstract][Full Text] [Related]
20. Circulating Exosomal Gastric Cancer-Associated Long Noncoding RNA1 as a Biomarker for Early Detection and Monitoring Progression of Gastric Cancer: A Multiphase Study. Guo X; Lv X; Ru Y; Zhou F; Wang N; Xi H; Zhang K; Li J; Chang R; Xie T; Wang X; Li B; Chen Y; Yang Y; Chen L; Chen L JAMA Surg; 2020 Jul; 155(7):572-579. PubMed ID: 32520332 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]